Effect of sialyl Lewis(x) oligosaccharide on myocardial and cerebral injury in the pig.

Abstract

BACKGROUND:

Although administration of the sialyl Lewis(x) oligosaccharide may reduce myocardial injury after ischemia-reperfusion, its effect on coronary and cerebral microvascular regulation and its clinical application during cardiac operation have not been examined.

METHODS:

Pigs were placed on normothermic cardiopulmonary bypass after 30 minutes of left anterior descending coronary artery occlusion. The hearts were then arrested with cold high potassium cardioplegia. After 1 hour the cross-clamp was removed and the pigs were weaned from cardiopulmonary bypass and perfused for an additional 1 hour. CY-1503 (a sodium salt of the sialyl Lewis(x) oligosaccharide, n = 6) was administered before reperfusion. Six other pigs received saline vehicle. Endothelium-dependent relaxation of precontracted coronary and brain arterioles (70 to 180 microm) to adenosine 5'-diphosphate and endothelium-independent relaxation to sodium nitroprusside were studied in vitro with videomicroscopy. Control values were obtained from uninstrumented pigs. Myeloperoxidase activity in the myocardium and brain was measured to quantify neutrophil infiltration. Cardiac function and perfusion were assessed by left ventricular systolic pressure, maximum rate of increase of left ventricular pressure, left anterior descending coronary artery blood flow and percent segmental shortening, and cerebral vascular resistance, internal carotid artery blood flow, and the constitutively expressed and inducible isoform of nitric oxide synthase mRNA were measured.

RESULTS:

The impaired myocardial contractile function after ischemia and cardioplegia was not improved by administration of CY-1503. The reduced endothelium-dependent relaxation responses of coronary and brain arterioles during ischemia followed by cardioplegia and cardiopulmonary bypass were improved with CY-1503, but the altered pattern of organ perfusion was not improved. Myeloperoxidase activity was increased in the heart after ischemia-cardioplegia and in the brain after cardiopulmonary bypass. CY-1503 reduced myeloperoxidase activity in both the myocardium and in the brain. Expressions of myocardial inducible isoform or constitutively expressed nitric oxide synthase were not altered in the heart.

CONCLUSIONS:

Although the sialyl Lewis(x) oligosaccharide does reduce neutrophil infiltration and endothelial injury in the coronary and cerebral microcirculation after cardiopulmonary bypass, it does not have significant beneficial acute effects on organ perfusion or function in the myocardium or brain.

• Authors: M Tofukuji, C Metais, C D Collard, D S Morse, G L Stahl, D P Nelson, J Li, M Simons, F W Sellke
• Journal: The Annals of thoracic surgery (Ann Thorac Surg) Vol. 67 Issue 1 Pg. 112-9 (Jan 1999) ISSN: 0003-4975 [Print] Netherlands
• PMID: 10086534 (Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)

Chemical References

• CY 1503
• Oligosaccharides
• Peroxidase

Topics

• Animals
• Brain (blood supply, enzymology, metabolism)
• Cardiopulmonary Bypass
• Endothelium, Vascular (physiology)
• Female
• Hemodynamics
• Leukocytes, Mononuclear (metabolism)
• Male
• Microcirculation (drug effects)
• Myocardial Contraction
• Myocardial Reperfusion Injury (prevention & control)
• Myocardium (enzymology)
• Neutrophils (metabolism)
• Oligosaccharides (pharmacology, therapeutic use)
• Peroxidase (metabolism)
• Reperfusion Injury (prevention & control)
• Swine
• Vasodilation (drug effects)